Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003)

Merck Sharp & Dohme LLC · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
breast-cancerpembrolizumabtriple-negative-breast-cancer
early triple negative breast cancer, triple negative breast cancer, breast cancer, neoadjuvant, boserolimab, pembrolizumab, umbrella study, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 835459
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.